The recall of a batch of Johnson & Johnson children’s cough syrup in several African countries has sparked concerns over the safety of the popular medication. Tanzania, Rwanda, and Zimbabwe have joined Nigeria, Kenya, and South Africa in recalling the syrup after tests revealed high levels of toxicity.
The Nigerian health regulator found elevated levels of diethylene glycol in the syrup, a substance linked to the deaths of children in other countries. Diethylene glycol is known to cause acute kidney failure in humans when consumed.
The batch of Benylin Paediatric syrup was manufactured by J&J in South Africa in May 2021, but is now owned by Kenvue following a spin-off last year. Tanzania’s Medicines and Medical Devices Authority initiated the recall after being informed of the Nigerian test results.
Kenya and Rwanda are also conducting tests on the syrup, with results expected soon. The Rwanda Food and Drugs Authority issued a statement emphasizing the importance of precautionary measures.
Zimbabwe’s Medicines Control Agency expressed concerns about the illegal importation of the syrup into the country and pledged to increase inspections to prevent its distribution.
Kenvue stated that they are conducting their own assessment and collaborating with health authorities to determine the best course of action. The recall serves as a reminder of the importance of stringent safety measures in the production and distribution of medications to protect consumers from potential harm.